drugset / Trial / NCT01378585

Safety and Efficacy of DLBS1033 in Healthy Subjects

NCT01378585

Completed 20 enrolled Dexa Medica Group
RandomizedCrossoverQuadruple-blindTreatment

Summary

The objective of this study are: 1. To evaluate the safety of DLBS1033 in comparison with placebo in healthy adult subject 2. To evaluate the efficacy of DLBS1033 in comparison with placebo in healthy adult subject

Timeline

Start
2011-05
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DLBS1033 Protein / enzyme biologic 490 mg

Indications

No indication recorded.